|
Year:
2022 |
Institution:
University of Washington |
Department:
Genome Sciences |
Type of Grant:
Postdoctoral Programs
WRF Postdoctoral Fellowship
|
Amount:
$26,250 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Biology |
Type of Grant:
Faculty Programs
Faculty recruitment
|
Amount:
$300,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Administration |
Type of Grant:
Sponsorships & Other
Miscellaneous sponsorships
|
Amount:
$3,500 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Chemistry |
Type of Grant:
Faculty Programs
Program support for Dr. David Ginger at the Clean Energy Institute
|
Amount:
$35,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Pharmacy |
Type of Grant:
Technology Commercialization
Phase 1 Technology Commercialization Grant: Investigational agents for epilepsy
|
Amount:
$37,674 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Biochemistry |
Type of Grant:
Technology Commercialization
Phase 1 Technology Commercialization Grant: Rapid identification of in cellulo active cyclic-peptides inhibiting ‘undruggable’ MYC associated targets
|
Amount:
$45,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Aquatic & Fishery Sciences |
Type of Grant:
Postdoctoral Programs
WRF Postdoctoral Fellowship
|
Amount:
$45,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Gerontology & Geriatric Medicine |
Type of Grant:
Postdoctoral Programs
WRF Postdoctoral Fellowship
|
Amount:
$45,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Physiology & Biophysics |
Type of Grant:
Postdoctoral Programs
WRF Postdoctoral Fellowship
|
Amount:
$45,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Biochemistry |
Type of Grant:
Technology Commercialization
Phase 1 Technology Commercialization Grant: Designed death receptor agonists
|
Amount:
$49,503 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
CIE, CTE and PEI |
Type of Grant:
Student Programs
Environmental Innovation Challenge prototype fund
|
Amount:
$5,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
CIE, CTE and PEI |
Type of Grant:
Student Programs
Health Innovation Challenge prototype fund
|
Amount:
$5,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Genome Sciences |
Type of Grant:
Technology Commercialization
Phase 1 Technology Commercialization Grant: Multiplexed in situ signal amplification with SLX
|
Amount:
$50,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Genome Sciences |
Type of Grant:
Technology Commercialization
Phase 1 Technology Commercialization Grant: Massively multiplexed single cell proteomics
|
Amount:
$50,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Biochemistry |
Type of Grant:
Technology Commercialization
Phase 1 Technology Commercialization Grant: Rapid identification of in cellulo active cyclic-peptides inhibiting ‘undruggable’ targets requiring sub-type binding specificity
|
Amount:
$50,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Mechanical Engineering |
Type of Grant:
Technology Commercialization
Phase 1 Technology Commercialization Grant: Measurements of dental implant stability
|
Amount:
$50,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Graduate School |
Type of Grant:
Student Programs
Research Exchange program
|
Amount:
$50,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Biochemistry |
Type of Grant:
Technology Commercialization
Phase 1 Technology Commercialization Grant: Oral, gut-restricted anti-IL-23R therapy for inflammatory bowel disease
|
Amount:
$63,000 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Electrical & Computer Engineering |
Type of Grant:
Postdoctoral Programs
WRF Postdoctoral Fellowship
|
Amount:
$69,375 |
|
Year:
2022 |
Institution:
University of Washington |
Department:
Biochemistry |
Type of Grant:
Technology Commercialization
Phase 3 Technology Commercialization Grant: Oral, gut-restricted anti-IL-23R therapy for inflammatory bowel disease
|
Amount:
$700,000 |